Global Asthma & COPD Market Report: 2015 Edition – New Report by Koncept Analytics

DELHI, India - Sept. 23, 2015 - PRLog -- Increasing global spending on medicines, increasing tobacco and cigarette consumption, rising prevalence of non-communicable diseases, more use of biologics, and increasing healthcare expenditure worldwideare some of the factors which are largely responsible for the growth of the asthma market worldwide. The prevalence of asthma is expected to increase significantly in the coming years. The major upcoming trends in the asthmamarket include introduction of new severe asthma and Chronic Obstructive Pulmonary Disease (COPD) drugs, and introduction of new mechanisms that will help drive the market.However, there are certain challenges hindering the growth of the market. Such challenges include increased pricing pressures, patent expiries and introduction of generic drugs in the market.

The research report,” Global Asthma Market Report: 2015 Edition” reveals that the globalasthma market is set to rise as potential opportunities lies in the developed and developing nations for asthma and COPD drugs.Due to effectiveness and advancements in technology, a large number of companies are focusing to develop innovative asthma and COPD drugs and treatments. Further, the companies are combining businesses and spending comprehensively on research and development to develop effective treatment methods for asthma.

The report by Koncept Analytics provides comprehensive research and unbiased analysis of the current market performance and future outlook of the global and key regional asthma market – the U.S. and Europe. Following this, the report provides the reader with an outlook of the current status of the asthma market and also encompasses a number of factors driving the growth of the global asthma market coupled with recent trends and challenges hindering the growth of the industry.

List of Charts

Treatment Guidelines for Asthma
Global Respiratory Market (2012-2018E)
Global Respiratory Market by Conditions (2014E)
Global Respiratory Market by Regions (2014E)
Global Respiratory Therapeutics Market (2010-2015E)
Global Respiratory Market by Drugs (2014E)
Global Inhaled Maintenance Respiratory Market by Value (2008-2025E)
Global Inhaled Maintenance Respiratory Market Volume by Prescription Equivalents (2008-2025E)
Global Inhalation Drugs Delivery Technologies Market (2013-2018E)
Global Inhalation Drug Delivery Technology by Products (2014)
Global Active Asthma Prevalence, Diagnosed and Treated Population (2014)
Global Asthma Market by Value (2012-2022E)
Global COPD Prevalence Rate by Countries (2014)
Global COPD Severity by Country (2014)
Global COPD Market by Value (2012-2022E)
Global Asthma/COPD Market by Region (2017E)
Global Asthma/COPD Therapeutic Market (2010-2015E)
Global Severe Asthma Biologics Market Forecast (2013-2022E)
Global Severe Asthma Biologics Market by Drugs (2022E)
The U.S. Asthma Diagnosed Population (2015E-2025E)
The U.S. Asthma Treated Population (2015E-2025E)
The U.S. PRS-080 Product Market and Penetration Rate (2021-2025E)
EU Asthma Diagnosed Population (2015E-2025E)
EU Asthma Treated Population (2015-2025E)
EU PRS-080 Product Market and Penetration Rate (2022-2025E)
Global Spending on Medicines (2007-2017E)
Global Cigarettes Consumption (1910-2014)
Global Deaths Occurred by NCDs by Region (2012)
Global Biologics Market (2008-2014E)
Global Gross Domestic Product Growth (2009-2014)
Global Healthcare Expenditure Per Capita (2009-2014E)
Global Respiratory Market Share by Company (2014)
Global Severe Asthma Market Share by Company (2022E)
AstraZeneca Revenue by Therapeutic Segment (2013/2014)
AstraZeneca Revenue by Regions (2013/2014)
AstraZeneca Revenue and Net profit (2010-2014)
AstraZeneca Pipeline Development Projects (2012-2014)
Merck and Co. Revenue by Segments (2013/2014)
Merck and Co. Revenue by Regions (2014)
Merck and Co. Revenue and Net Income (2010-2014)
Merck and Co. Research and Development Expenditure (2010-2014)
Roche’s Revenue by Business Segments (2014)
Roche’s Revenue and Net Income (2010-2014)
Sanofi Revenue by Segments (2013/2014)
Sanofi Revenue by Regions (2013/2014)
Sanofi Sales and Net Income (2010-2014)
Novartis Revenue by Business Segments (2014)
Novartis Revenues (2010-2014)

List of Tables

Common Asthma Triggers
Distinguishing Feature of Asthma and COPD
Treatment Guidelines for COPD
Investigational Treatment for Severe Asthma
Selective New Drugs for COPD
Global Respiratory Market by Company (2011-2015E)

Note:  Purchase by Section Also Available

For more Information:

http://www.konceptanalytics.com/Researchreport/global-asthma-copd-market-report-2015-edition-229.aspx

Koncept Analytics

Vikas Gupta

(Business Development Manager)

FFCS-36, Ansal Plaza

Vaishali, Ghaziabad

U.P - 201010

Tele: +91-120-4130959

Mobile: +91-9811715635

Mail ID – vikas@konceptanalytics.com

Koncept Analytics is a market research company. We are in the field of Market Research from last 10 Years. We do research in telecommunication, healthcare, pharmaceutical, financial services, energy, technology, real estate, logistics, food & beverages and media sectors. For more information:

http://www.konceptanalytics.com